- Implantable SNS
- External SNS
Sacral Nerve Stimulation Market size was valued at USD 2,167.3 million in 2023 and is expected to grow at a significant CAGR of 12.7% from 2024-2030. The global market provides a detailed overview of the Sacral Nerve Stimulation Market and that can be segmented into product type, technology, application, and end-user. By product type, the sacral nerve stimulation market has been segmented into Implantable SNS and external SNS. The implantable SNS segment is likely to be the largest and fastest-growing segment in terms of connectivity. Based on technology, the sacral nerve stimulation market is segmented into Electrical Muscle Stimulation and transcutaneous Electrical Nerve Stimulation. Among these, the electrical muscle stimulation segment is expected to have the fastest-growing market during the forecast period. Based on application, the sacral nerve stimulation market is segmented into Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, and Others. Urinary & Fecal Incontinence are expected to dominate the market in the future. Based on end-users, the market has been segmented into Hospitals, Ambulatory Surgical Centers, and Others. The hospital segment is expected to grow at the highest CAGR over the forecast years according to Precision Business Insights.
Sacral Nerve Stimulation Market Key Development:
In April 2022, Axonics Modulation Technologies launched the F15 recharge-free SNM (Sacral Nerve Stimulation) system. The advent of this SNM system proved to be a blessing for patients suffering from various bowel and bladder dysfunctions.
Sacral Nerve Stimulation Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
12.7%
Largest Market
North American
Fastest Growing Market
Asia-Pacific
Sacral Nerve Stimulation Market Dynamics
Factors such increasing cases of urge incontinence, Urinary Tract Infection (UTI), Overactive Bladder (OAB), and faecal incontinence are some of the key factors propelling the market growth.
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Sacral Nerve Stimulation Market Segmentation
By Product Type
By Technology
- Electrical Muscle Stimulation
- Transcutaneous Electrical Nerve Stimulation
By Application
- Urinary & Fecal Incontinence
- Urge Incontinence
- Chronic Anal Fissure
- Others
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Frequently Asked Questions
The sacral nerve stimulation market size was valued at USD 2,167.3 million in 2023
The major players in the global Sacral Nerve Stimulation market are Axonics Modulation Technologies Inc., Biomedical Life Systems Inc., Boston Scientific Corporation, EnteroMedics Inc., Inspire Medical Systems Inc., Johnson and Johnson, Kegel8 (Savantini Limited), Laborie Inc., LivaNova PLC, Medtronic PLC, NeuroPace Inc., Nevro Corp., Nuvectra Corporation, . St. Jude Medical Inc. (Abbott Laboratories), Synapse Biomedical Inc.
North America is the fastest-growing region for sacral nerve stimulation market
| 1. Executive Summary |
| 2. Global Sacral Nerve Stimulation Market Introduction |
| 2.1. Global Sacral Nerve Stimulation Market Taxonomy |
| 2.2. Global Sacral Nerve Stimulation Market Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Technology |
| 2.2.3. By Application |
| 2.2.4. By End User |
| 3. Global Sacral Nerve Stimulation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Sacral Nerve Stimulation Market Dynamics Factors Impact Analysis |
| 4. Global Sacral Nerve Stimulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Sacral Nerve Stimulation Market Forecast, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 |
| 5.1. Implantable SNS |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. External SNS |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Sacral Nerve Stimulation Market Forecast, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 |
| 6.1. Electrical Muscle Stimulation |
| 6.1.1. Transcutaneous Electrical Nerve Stimulation |
| 6.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.1.3. Market Opportunity Analysis |
| 7. Global Sacral Nerve Stimulation Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030 |
| 7.1. Urinary & Fecal Incontinence |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Urge Incontinence |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Chronic Anal Fissure |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Sacral Nerve Stimulation Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Ambulatory Surgical Centers |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Others |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Sacral Nerve Stimulation Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. The Middle East & Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Sacral Nerve Stimulation Market - Opportunity Analysis Index, By Product Type, By Technology, By Application, By End User, and Region, 2024 - 2030 |
| 10. North America Sacral Nerve Stimulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 10.1. Product Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Implantable SNS |
| 10.1.2. External SNS |
| 10.2. Technology Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Electrical Muscle Stimulation |
| 10.2.2. Transcutaneous Electrical Nerve Stimulation |
| 10.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Urinary & Fecal Incontinence |
| 10.3.2. Urge Incontinence |
| 10.3.3. Chronic Anal Fissure |
| 10.3.4. Others |
| 10.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Hospitals |
| 10.4.2. Ambulatory Surgical Centers |
| 10.4.3. Others |
| 10.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. U.S. |
| 10.5.2. Canada |
| 10.6. North America Sacral Nerve Stimulation Market - Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2024 - 2030 |
| 10.7. North America Sacral Nerve Stimulation Market Dynamics Trends |
| 11. Europe Sacral Nerve Stimulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 11.1. Product Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Implantable SNS |
| 11.1.2. External SNS |
| 11.2. Technology Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Electrical Muscle Stimulation |
| 11.2.2. Transcutaneous Electrical Nerve Stimulation |
| 11.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Urinary & Fecal Incontinence |
| 11.3.2. Urge Incontinence |
| 11.3.3. Chronic Anal Fissure |
| 11.3.4. Others |
| 11.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Hospitals |
| 11.4.2. Ambulatory Surgical Centers |
| 11.4.3. Others |
| 11.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. U.K. |
| 11.5.2. Germany |
| 11.5.3. France |
| 11.5.4. Italy |
| 11.5.5. Spain |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Sacral Nerve Stimulation Market - Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2024 - 2030 |
| 11.7. Europe Sacral Nerve Stimulation Market Dynamics Trends |
| 12. Asia Pacific Sacral Nerve Stimulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 12.1. Product Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Implantable SNS |
| 12.1.2. External SNS |
| 12.2. Technology Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Electrical Muscle Stimulation |
| 12.2.2. Transcutaneous Electrical Nerve Stimulation |
| 12.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Urinary & Fecal Incontinence |
| 12.3.2. Urge Incontinence |
| 12.3.3. Chronic Anal Fissure |
| 12.3.4. Others |
| 12.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Hospitals |
| 12.4.2. Ambulatory Surgical Centers |
| 12.4.3. Others |
| 12.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. Japan |
| 12.5.3. India |
| 12.5.4. ASEAN Counties |
| 12.5.5. Rest of Asia Pacific |
| 12.6. Asia Pacific Sacral Nerve Stimulation Market - Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2024 - 2030 |
| 12.7. Asia Pacific Sacral Nerve Stimulation Market Dynamics Trends |
| 13. Latin America Sacral Nerve Stimulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 13.1. Product Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Implantable SNS |
| 13.1.2. External SNS |
| 13.2. Technology Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Electrical Muscle Stimulation |
| 13.2.2. Transcutaneous Electrical Nerve Stimulation |
| 13.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Urinary & Fecal Incontinence |
| 13.3.2. Urge Incontinence |
| 13.3.3. Chronic Anal Fissure |
| 13.3.4. Others |
| 13.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Hospitals |
| 13.4.2. Ambulatory Surgical Centers |
| 13.4.3. Others |
| 13.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Mexico |
| 13.5.2. Brazil |
| 13.5.3. Argentina |
| 13.5.4. Chile |
| 13.5.5. Rest of Latin America |
| 13.6. Latin America Sacral Nerve Stimulation Market - Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2024 - 2030 |
| 13.7. Latin America Sacral Nerve Stimulation Market Dynamics Trends |
| 14. Middle East and Africa Sacral Nerve Stimulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 14.1. Product Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Implantable SNS |
| 14.1.2. External SNS |
| 14.2. Technology Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Electrical Muscle Stimulation |
| 14.2.2. Transcutaneous Electrical Nerve Stimulation |
| 14.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1. Urinary & Fecal Incontinence |
| 14.3.2. Urge Incontinence |
| 14.3.3. Chronic Anal Fissure |
| 14.3.4. Others |
| 14.4. End User Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1. Hospitals |
| 14.4.2. Ambulatory Surgical Centers |
| 14.4.3. Others |
| 14.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. GCC Countries |
| 14.5.2. South Africa |
| 14.5.3. Turkey |
| 14.5.4. Rest of MEA |
| 14.6. Middle East and Africa Sacral Nerve Stimulation Market - Opportunity Analysis Index, By Product, By Technology, By Application, By End User, and Country, 2024 - 2030 |
| 14.7. Middle East and Africa Sacral Nerve Stimulation Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Axonics Modulation Technologies Inc. |
| 15.2.2. Biomedical Life Systems Inc. |
| 15.2.3. Boston Scientific Corporation |
| 15.2.4. EnteroMedics Inc. |
| 15.2.5. Inspire Medical Systems Inc. |
| 15.2.6. Johnson and Johnson |
| 15.2.7. Kegel8 (Savantini Limited) |
| 15.2.8. Laborie Inc. |
| 15.2.9. LivaNova PLC |
| 15.2.10. Medtronic PLC |
| 15.2.11. NeuroPace Inc. |
| 15.2.12. Nevro Corp. |
| 15.2.13. Nuvectra Corporation |
| 15.2.14. St. Jude Medical Inc. (Abbott Laboratories) |
| 15.2.15. Synapse Biomedical Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Axonics Modulation Technologies Inc.
- Biomedical Life Systems Inc.
- Boston Scientific Corporation
- EnteroMedics Inc.
- Inspire Medical Systems Inc.
- Johnson and Johnson
- Kegel8 (Savantini Limited)
- Laborie Inc.
- LivaNova PLC
- Medtronic PLC
- NeuroPace Inc.
- Nevro Corp.
- Nuvectra Corporation
- St. Jude Medical Inc. (Abbott Laboratories)
- Synapse Biomedical Inc.